Keeping up the right drug levels in your body is important for lowering your viral load to undetectable and reducing the chance of drug resistance.
After 144 weeks, this clinical trial found that a treatment based on an EVOTAZ regimen was comparable to an atazanavir/ritonavir-based regimen.
*M184V resistance mutation to emtricitabine.
Do not take EVOTAZ if you:
Before taking EVOTAZ, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Some medicines interact with EVOTAZ. Keep a list of your medicines and show it to your healthcare provider and pharmacist. Do not start taking any new medicines without first talking to your healthcare provider.
EVOTAZ can cause serious side effects, including:
The most common side effects of EVOTAZ are yellowing of the skin and rash.
These are not all the possible side effects of EVOTAZ.
Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Please see Full Prescribing Information, including Patient Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.